Introducing Digital Psychiatry
A new open access journal from Taylor & Francis
Digital Psychiatry is a new international, peer-reviewed, open access journal from Taylor & Francis, focusing on e-health and digital applications of technologies in psychiatry.
Digital Psychiatry covers the following topics:
• E-health matters with a clear focus on mental health/psychiatry
• Technical innovations in the area of digital psychiatry
• Computerized applications in psychiatry
• Clinical psychiatry
• Digital policy making and evaluation
We publish original articles, review articles, debate and special topic issues.
What do we publish?
We publish original articles, review and debate papers, in addition to special issues on a variety of topics relevant to e-health and digital psychiatry. All accepted papers will be published gold open access, meaning that all research from the journal will be freely and permanently available online.
Why do we only publish research open access?
Open access enables research to be made freely and permanently available online for anyone, anywhere to read.
We believe that it is critical that the academic studies published in Digital Psychiatry are disseminated openly for all researchers. In today’s academic world, it is essential to spread knowledge and let everyone share in the findings of our research.
Open access also has a number of benefits for authors:
- Unlimited reach: Your paper will be freely available for anyone, anywhere to read.
- Increased readership: Open access research typically receives greater and more varied readership compared to traditionally-published articles. Your paper could be read and cited by fellow researchers and practitioners all over the world
- Influence clinical practice: No barriers to readership means your research can read beyond academia and inform and influence real clinical practice from psychiatrists all over the world.
The context for our journal
Until recently, psychiatrists have been confined to relying on disease history narratives and observational clinical symptom data to support diagnosis and treatment.
However, recent austerity measures in combination with the rapid development of new technologies have led to a revelation among psychiatrists about the huge potential of modern technology to improve practice.
For example, we now have new apps for collecting clinically-relevant information directly from patients; wearable devices which can provide us with longitudinal observations; avatar therapy which can address delusions and hallucinations; in addition to other forms of virtual reality devices which can be used for phobia desensitisation.
These are a few examples of new technologies that Digital Psychiatry is interested in exploring.
What we are looking for
We are currently seeking submissions for our 2019 issue.
The Editorial Board of Digital Psychiatry are specifically interested in manuscripts from authors who are involved in:
- Psychiatric research utilising advanced technology as a tool with potential for direct implementation into clinical practice (for both diagnostic or therapeutic purposes);
- Other research projects and methodological descriptions of medical devices being used in psychiatry;
- Research using machine learning for developing clinical decision algorithms and/or ‘big data’ collection as a means of improving clinical practice;
- Research around distance and/or internet therapy.
Questions about publishing open access?
Our Editorial Board
Jonas Eberhard - Lund University, Lund, Sweden
Maria Faurholt-Jepsen - Psychiatric Center Copenhagen, Copenhagen, Denmark
Ulf Malm - Sahlgrenska University Hospital, Gothenburg, Sweden
Eduard Maron - University of Tartu, Estonia
Ingrid Andersson - Al Harub Medical Centre, Muscat, Oman
Jean Delahousse - Semantic Technologies Consultant, Paris, France
Damon Tojjar - Lund University, Lund, Sweden
Digital Psychiatry Advisors:
Julie O´Donnell - Medit, Dublin, Ireland
Russ Pendleton - Invisio, UK
Gerhard Andersson - University of Linköping, Sweden
Michael Davidson - Sackler School of Medicine, Tel Aviv, Israel
Guy Goodwin - University of Oxford, Oxford, UK
Simon Kung - Mayo Clinic, USA
Stefan Leucht - Technical University Munich, Germany
Pierre-Michel Llorca - University Clermont Auvergne, France
Nadja Maric - University of Belgrade, Belgrade, Serbia
Roger McIntyre - University of Toronto, Toronto, Canada
Janet Munro - Institut National de la Santé et de la Recherche Medical (INSERM), Montpellier, France
Martin Schalling - Karolinska Institutet, Stockholm, Sweden
Jim Van Os - UMC Utrecht, Utrecht, The Netherlands